Patients with relapsed/refractory leukemia and lymphomas generally have a grim prognosis, which has paved the way for immunotherapy treatments.
Caitlyn Tompkins, PharmD
Advertisement
Articles by Caitlyn Tompkins, PharmD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves First-in-Class Daraxonrasib for Metastatic Pancreatic Cancer
2
FDA Grants Fast Track Designation to CK0803 for Amyotrophic Lateral Sclerosis
3
Yeast-Based Universal Flu Vaccine Fully Protects Mice Against 3 Influenza Strains
4
Pharmacists' Expanding Role in MASLD Screening and Care
5